Infections associated with bendamustine and anti-CD20 antibody in untreated follicular lymphoma: a real-world study-Reference-Cited by-同舟云学术

Infections associated with bendamustine and anti-CD20 antibody in untreated follicular lymphoma: a real-world study

Published:2023 Issue:3 Volume:63 Page:197-200
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Saburi Masuho¹,Okuhiro Kazuki²,Yoshida Natsumi²,Haruyama Takami²,Moroga Yui²,Yanai Yuka²,Itani Kazuhito²,Takano Kuniko²,Honda Shuhei³,Ono Keiji⁴,Iwanaga Manami⁵,Sasaki Hitohiro⁵,Abe Miyuki⁵,Kohno Kazuhiro⁵,Nakayama Toshiyuki⁵,Ohtsuka Eiichi¹,Ogata Masao²

Affiliation:

1. Department of Hematology, Oita Prefectural Hospital, Oita, Japan,

2. Department of Hematology, Oita University Hospital, Oita, Japan,

3. Department of Hematology, JCHO Nankai Medical Center, Oita, Japan,

4. Department of Hematology, Almeida Memorial Hospital, Oita, Japan,

5. Department of Hematology, Oita Kouseiren Tsurumi Hospital, Oita, Japan

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/63/3/63_23015/_pdf

Reference13 articles.

1. 1 Jaffe ES, Harris NL, Swerdlow SH, et al. Follicular lymphoma. WHO classiﬁcation of tumours of haematopoietic and lymphoid tissues. Revised Fourth Edition, Lyon, IARC Press. 2017; pp. 266-277.

2. 2 Rummel MJ, Niederle N, Maschmeyer G et al. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet. 2013; 381: 1203-1210.

3. 3 Derenzini E, Zinzani PL, Cheson BD. Bendamustine: role and evidence in lymphoma therapy, an overview. Leuk Lymphoma. 2014; 55: 1471-1478.

4. 4 Gil L, Kazmierczak M, Kroll-Balcerzak R, Komarnicki M. Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma. Med Oncol. 2014; 31: 944.

5. 5 Gafter-Gvili A, Polliack A. Bendamustine associated immune suppression and infections during therapy of hematological malignancies. Leuk Lymphoma. 2016; 57: 512-519.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus Occurrence and Time-to-onset Analysis Under Bendamustine With Anti-CD20 Antibodies Using the JADER Database;In Vivo;2024